GlassScriptPhysician profile
Paresh A Patel
NPI 1780668244
$2,487.29
in general payments reported to CMS, 2019-2025
20 companies · $263 in 2025
The $263 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $131 · 2020: $232 · 2021: $384 · 2022: $267 · 2023: $609 · 2024: $602 · 2025: $263.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,474.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,474.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,268.85 | 2021-2025 | |
| Janssen Pharmaceuticals, INC | $263.29 | 2023 | Xarelto |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $191.27 | 2022-2025 | Lifevest |
| Allergan, INC. | $179.80 | 2020 | |
| Astrazeneca Pharmaceuticals LP | $121.85 | 2024 | Airsupra |
| Merck Sharp & Dohme LLC | $85.85 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $55.41 | 2021 | |
| Dexcom, INC. | $45.79 | 2024 | Dexcom G6 Transmitter |
| Cook Medical LLC | $41.55 | 2024 | Blue Rhino |
| Pfizer INC. | $29.83 | 2023 | |
| Amarin Pharma, INC. | $29.60 | 2020 | |
| Emd Serono, INC. | $27.69 | 2023 | Bavencio |
| Abbott Laboratories | $24.79 | 2024 | Supera |
| Bayer Healthcare Pharmaceuticals INC. | $22.29 | 2021 | |
| Astellas Pharma US INC | $22.10 | 2020 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Insmed, INC. | $18.12 | 2025 | Brinsupri, Arikayce |
| Partner Therapeutics, INC. | $16.06 | 2019 | |
| Novo Nordisk INC | $15.38 | 2019 | |
| Amgen INC. | $13.89 | 2022 | |
| Novartis Pharmaceuticals Corporation | $13.88 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paresh Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.